Orlistat-associated adverse effects and drug interactions: a critical review.
Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS.
Drug Saf. 2008;31(1):53-65. doi: 10.2165/00002018-200831010-00005.
Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey.
You S, Rong Y, Zhu B, Zhang A, Zang H, Liu H, Li D, Wan Z, Xin S.
Hepatol Int. 2013 Jun;7(2):714-20. doi: 10.1007/s12072-013-9424-5. Epub 2013 Feb 7.
Bacterial infections complicating liver disease.
Wyke RJ.
Baillieres Clin Gastroenterol. 1989 Jan;3(1):187-210. doi: 10.1016/0950-3528(89)90052-3.
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection.
Gómez-Medina C, Melo L, Martí-Aguado D, Bataller R.
Clin Mol Hepatol. 2023 Jan;29(1):1-15. doi: 10.3350/cmh.2022.0017. Epub 2022 Apr 15.
[Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021].
Xu MM, Li SS, Yang YR, Wu Y, Yang X, Duan ZP, Chen Y.
Zhonghua Gan Zang Bing Za Zhi. 2024 Jan 20;32(1):49-57. doi: 10.3760/cma.j.cn501113-20220824-00433.
Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.
Amini M, Runyon BA.
World J Gastroenterol. 2010 Oct 21;16(39):4905-12. doi: 10.3748/wjg.v16.i39.4905.
[Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-on-chronic liver failure].
Liu XY, Hu JH, Wang HF, Chen JM.
Zhonghua Gan Zang Bing Za Zhi. 2008 Oct;16(10):772-5.
The role of EEG and neuroimaging in the diagnosis of non-convulsive status epilepticus in Subacute Encephalopathy with Seizures in Alcoholics (SESA syndrome): a case report and overview of the literature.
Biassoni E, Bellucci M, Micalizzi E, Miggino M, Andorno E, Porcile E, Resaz M, Roccatagliata L, Castellan L, Villani F, Ferrari A.
Neurol Sci. 2024 Oct;45(10):5053-5062. doi: 10.1007/s10072-024-07609-2. Epub 2024 May 27.
Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective.
Tana C, Schiavone C, Ticinesi A, Lauretani F, Nouvenne A, Dietrich CF, Meschi T.
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418781373. doi: 10.1177/2058738418781373.
Feasibility of auxiliary partial living donor liver transplantation for fulminant hepatic failure as an aid for small-for-size graft: single center experience.
Kobayashi T, Sato Y, Yamamoto S, Oya H, Hara Y, Watanabe T, Kokai H, Hatakeyama K.
Transplant Proc. 2009 Jan-Feb;41(1):262-4. doi: 10.1016/j.transproceed.2008.10.025.
